研究动态
Articles below are published ahead of final publication in an issue. Please cite articles in the following format: authors, (year), title, journal, DOI.

TRIM69 通过泛素蛋白酶体介导的 PRKCD 降解抑制胃癌的失巢凋亡抵抗和转移。

TRIM69 suppressed the anoikis resistance and metastasis of gastric cancer through ubiquitin‒proteasome-mediated degradation of PRKCD.

发表日期:2023 Oct 20
作者: Linqing Sun, Yuqi Chen, Lu Xia, Jiayu Wang, Jinghan Zhu, Juntao Li, Kun Wang, Kanger Shen, Dongze Zhang, Guangbo Zhang, Tongguo Shi, Weichang Chen
来源: ONCOGENE

摘要:

三联基序 (TRIM) 蛋白家族已在多种人类癌症中进行了研究,包括胃癌 (GC)。然而,TRIM69在GC细胞失巢凋亡抵抗和转移中的作用仍有待阐明。我们使用 RNA 测序分析鉴定了抗失巢凋亡 GC 细胞中的差异表达基因。通过免疫共沉淀和质谱分析 TRIM69 和 PRKCD 之间的相互作用。我们的结果表明 TRIM69 在抗失巢凋亡的 GC 细胞中显着下调。 TRIM69过表达显着抑制体外和体内GC细胞的失巢凋亡抵抗和转移。 TRIM69 敲低产生相反的效果。从机制上讲,TRIM69 通过其 B-box 结构域与 PRKCD 相互作用,并催化 PRKCD 的 K48 连接的多聚泛素化。此外,TRIM69 以 PRKCD 依赖性方式抑制 BDNF 的产生。重要的是,PRKCD 或 BDNF 的过表达阻断了 TRIM69 对 GC 细胞失巢凋亡抵抗和转移的影响。有趣的是,TRIM69-PRKCD BDNF 细胞亚群与 GC 患者的转移呈正相关。 TRIM69 通过调节 PRKCD/BDNF 轴介导的失巢凋亡抵抗和 GC 细胞转移的抑制,对转移性 GC 的新治疗方法具有潜在影响。© 2023。作者,获得 Springer Nature Limited 的独家许可。
The tripartite motif (TRIM) protein family has been investigated in multiple human cancers, including gastric cancer (GC). However, the role of TRIM69 in the anoikis resistance and metastasis of GC cells remains to be elucidated. We identified the differentially expressed genes in anoikis-resistant GC cells using RNA-sequencing analysis. The interaction between TRIM69 and PRKCD was analyzed by coimmunoprecipitation and mass spectrometry. Our results have shown that TRIM69 was significantly downregulated in anoikis-resistant GC cells. TRIM69 overexpression markedly suppressed the anoikis resistance and metastasis of GC cells in vitro and in vivo. TRIM69 knockdown had the opposite effects. Mechanistically, TRIM69 interacted with PRKCD through its B-box domain and catalyzed the K48-linked polyubiquitination of PRKCD. Moreover, TRIM69 inhibited BDNF production in a PRKCD-dependent manner. Importantly, overexpression of PRKCD or BDNF blocked the effects of TRIM69 on the anoikis resistance and metastasis of GC cells. Interestingly, a TRIM69-PRKCD+BDNF+ cell subset was positively associated with metastasis in GC patients. TRIM69-mediated suppression of the anoikis resistance and metastasis of GC cells via modulation of the PRKCD/BDNF axis, with potential implications for novel therapeutic approaches for metastatic GC.© 2023. The Author(s), under exclusive licence to Springer Nature Limited.